Found: 224
Select item for more details and to access through your institution.
Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1069, doi. 10.1002/ehf2.12355
- By:
- Publication type:
- Article
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2578, doi. 10.1111/dom.15572
- By:
- Publication type:
- Article
Glucagon‐like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta‐analysis of randomized placebo‐controlled outcome trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1495, doi. 10.1111/dom.14997
- By:
- Publication type:
- Article
Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1143, doi. 10.1111/dom.14963
- By:
- Publication type:
- Article
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 189, doi. 10.1111/dom.14862
- By:
- Publication type:
- Article
Interplay of adenosine monophosphate‐activated protein kinase/sirtuin‐1 activation and sodium influx inhibition mediates the renal benefits of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: A novel conceptual framework
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 734, doi. 10.1111/dom.13961
- By:
- Publication type:
- Article
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1765, doi. 10.1111/dom.13792
- By:
- Publication type:
- Article
Higher mortality rate in patients with heart failure who are taking commonly prescribed antidiabetic medications and achieve recommended levels of glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1766, doi. 10.1111/dom.13265
- By:
- Publication type:
- Article
Do sodium‐glucose co‐transporter‐2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1361, doi. 10.1111/dom.13229
- By:
- Publication type:
- Article
Have we really demonstrated the cardiovascular safety of anti‐hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1089, doi. 10.1111/dom.13207
- By:
- Publication type:
- Article
Role of the sodium‐hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 800, doi. 10.1111/dom.13191
- By:
- Publication type:
- Article
How carvedilol does not activate β<sub>2</sub>-adrenoceptors.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1883, doi. 10.1001/jama.297.17.1883
- By:
- Publication type:
- Article
Effects of Initiating Carvedilol in Patients With Severe Chronic Heart Failure: Results From the COPERNICUS Study.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 6, p. 712, doi. 10.1001/jama.289.6.712
- By:
- Publication type:
- Article
Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Clinical trials in congestive heart failure: why do studies report conflicting results?
- Published in:
- 1988
- By:
- Publication type:
- journal article
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Influence of Renal Function on the Hemodynamic and Clinical Responses to Long-Term Captopril Therapy in Severe Chronic Heart Failure.
- Published in:
- Annals of Internal Medicine, 1986, v. 104, n. 2, p. 147, doi. 10.7326/0003-4819-104-2-147
- By:
- Publication type:
- Article
Vasodilator Therapy for Primary Pulmonary Hypertension.
- Published in:
- Annals of Internal Medicine, 1985, v. 103, n. 2, p. 258, doi. 10.7326/0003-4819-103-2-258
- By:
- Publication type:
- Article
Correction of Dilutional Hyponatremia in Severe Chronic Heart Failure by Converting-Enzyme Inhibition.
- Published in:
- Annals of Internal Medicine, 1984, v. 100, n. 6, p. 782, doi. 10.7326/0003-4819-100-6-782
- By:
- Publication type:
- Article
Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01946-w
- By:
- Publication type:
- Article
Do amiodarone and dronedarone prevent thrombo-embolic stroke by treating the atrial myopathy of patients with atrial fibrillation? A provocative hypothesis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effect of treatment on survival in congestive heart failure.
- Published in:
- Clinical Cardiology, 1992, v. 15, n. 5, p. 323, doi. 10.1002/clc.4960150504
- By:
- Publication type:
- Article
Issues in regulatory guidelines for data monitoring committees.
- Published in:
- Clinical Trials, 2004, v. 1, n. 2, p. 162, doi. 10.1191/1740774504cn019xx
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01545-1
- By:
- Publication type:
- Article
Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis.
- Published in:
- Nature, 2012, v. 481, n. 7382, p. 511, doi. 10.1038/nature10758
- By:
- Publication type:
- Article
Redefining Heart Failure With a Reduced Ejection Fraction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Central hemodynamic effects of dipyridamole in severe heart failure: Comparison with hydralazine.
- Published in:
- Clinical Pharmacology & Therapeutics, 1982, v. 32, n. 1, p. 54, doi. 10.1038/clpt.1982.126
- By:
- Publication type:
- Article
Hemodynamic evaluation of hydralazine dosage in refractory heart failure.
- Published in:
- Clinical Pharmacology & Therapeutics, 1980, v. 27, n. 3, p. 337, doi. 10.1038/clpt.1980.45
- By:
- Publication type:
- Article
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2024, v. 15, n. 1, p. 412, doi. 10.1002/jcsm.13393
- By:
- Publication type:
- Article
Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2017, v. 8, n. 4, p. 549, doi. 10.1002/jcsm.12191
- By:
- Publication type:
- Article
Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction.
- Published in:
- JAMA: Journal of the American Medical Association, 1991, v. 266, n. 4, p. 528, doi. 10.1001/jama.1991.03470040092028
- By:
- Publication type:
- Article
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia.
- Published in:
- American Journal of Nephrology, 2024, v. 55, n. 2, p. 255, doi. 10.1159/000531084
- By:
- Publication type:
- Article
Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Identification of three mechanistic pathways for iron-deficient heart failure.
- Published in:
- European Heart Journal, 2024, v. 45, n. 26, p. 2281, doi. 10.1093/eurheartj/ehae284
- By:
- Publication type:
- Article
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction.
- Published in:
- European Heart Journal, 2024, v. 45, n. 25, p. 2186, doi. 10.1093/eurheartj/ehae300
- By:
- Publication type:
- Article
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5027, doi. 10.1093/eurheartj/ehad235
- By:
- Publication type:
- Article
Acetazolamide for acute heart failure: is ADVOR a riddle wrapped in a mystery inside an enigma?
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3683, doi. 10.1093/eurheartj/ehad560
- By:
- Publication type:
- Article
Stroke in patients with heart failure and reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2998, doi. 10.1093/eurheartj/ehad338
- By:
- Publication type:
- Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2202, doi. 10.1093/eurheartj/ehad210
- By:
- Publication type:
- Article
Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
- Published in:
- European Heart Journal, 2023, v. 44, n. 17, p. 1522, doi. 10.1093/eurheartj/ehad158
- By:
- Publication type:
- Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1136, doi. 10.1093/eurheartj/ehad083
- By:
- Publication type:
- Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 668, doi. 10.1093/eurheartj/ehac801
- By:
- Publication type:
- Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 396, doi. 10.1093/eurheartj/ehac693
- By:
- Publication type:
- Article
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 4991, doi. 10.1093/eurheartj/ehac495
- By:
- Publication type:
- Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4469, doi. 10.1093/eurheartj/ehac487
- By:
- Publication type:
- Article
Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4374, doi. 10.1093/eurheartj/ehac399
- By:
- Publication type:
- Article
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3435, doi. 10.1093/eurheartj/ehac320
- By:
- Publication type:
- Article
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306
- By:
- Publication type:
- Article